Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Dermatoscopy and videodermatoscopy are useful for diagnosing and monitoring various skin, hair, and nail conditions.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

Most pregnant women experience skin darkening and hair changes, with these effects usually going away after giving birth.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Menopause affects hair and skin; more research needed for treatment.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

The document reports the first Brazilian case of a girl with Becker nevus syndrome, characterized by skin changes, breast underdevelopment, and scoliosis.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.

More men are getting cosmetic procedures, mainly for aging, hair loss, and to keep masculine features, with growing interest in both surgical and noninvasive treatments.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

A girl with Becker's nevus syndrome showed good improvement in breast development using spironolactone.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.